Heron Therapeutics, Inc. announced that the FDA has approved Sustol (granisetron) extended-release injection. Sustol is a serotonin-3 (5-HT3) receptor antagonist...
Heron Therapeutics, Inc. announced that it has resubmitted its New Drug Application (NDA) to the FDA for Sustol (granisetron) Injection,...
Heron Therapeutics, Inc., announced positive, top-line results from its recently completed Phase III MAGIC study. MAGIC evaluated the efficacy and...
Heron Therapeutics, Inc.has announced that the FDA has approved Cinvanti (aprepitant) injectable emulsion, for intravenous infusion. Cinvanti is a substance...